Kronos Bio (KRON) News Today → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free KRON Stock Alerts $1.00 +0.02 (+2.04%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineKronos Bio (NASDAQ:KRON) Trading 1.1% Higher americanbankingnews.com - April 25 at 1:48 AMKronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meetingglobenewswire.com - April 24 at 4:01 PMKronos Bio (NASDAQ:KRON) Stock Price Down 8%marketbeat.com - April 3 at 2:15 AM5 Boutique Fitness Studios in Bangkok for an Elevated Workout Experiencemsn.com - March 31 at 9:36 PMAnalysts Offer Insights on Healthcare Companies: Kronos Bio (KRON), Axsome Therapeutics (AXSM) and Sotera Health (SHC)markets.businessinsider.com - March 26 at 8:45 PMRecap: Kronos Bio Q4 Earningsbenzinga.com - March 21 at 7:25 PMKronos Bio reports Q4 resultsmsn.com - March 21 at 7:25 PMKRON Stock Earnings: Kronos Bio Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 21 at 2:05 PMKronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Resultsglobenewswire.com - March 21 at 7:05 AMKRON Kronos Bio, Inc.seekingalpha.com - March 19 at 10:07 AMKronos Bio (KRON) Scheduled to Post Quarterly Earnings on Wednesdaymarketbeat.com - March 12 at 7:35 AMCancer drug developer Kronos Bio slashes staffing for 2nd time in 4 monthsbizjournals.com - March 8 at 12:48 PMKronos Bio to Cut About 21% of Workforcemarketwatch.com - March 7 at 9:22 PMKronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runwayglobenewswire.com - March 7 at 4:05 PMKronos Bio To Present Three Posters at AACR 2024 Annual Meetingglobenewswire.com - March 5 at 4:44 PMKronos Bio Announces Participation in 44th Annual Cowen Health Care Conferenceglobenewswire.com - February 27 at 4:05 PMKronos Bio, Inc. (KRON)finance.yahoo.com - February 27 at 10:11 AMKRON Mar 2024 2.500 putfinance.yahoo.com - February 26 at 12:33 AMKronos Bio Incedition.cnn.com - February 22 at 10:23 AMGroundbreaking Live Clinical Cases Completed with the Single Pass KRONOS Biopsy Closure Devicefinance.yahoo.com - February 21 at 1:55 AMSingle Pass’ biopsy device completes initial live clinical cases in Italymsn.com - February 21 at 1:55 AMBuy Rating Affirmed for Kronos Bio Amid Restructuring and Promising KB-0742 Clinical Datamarkets.businessinsider.com - January 26 at 8:36 PMKronos Bio streamlines leadership, cuts CMO,CSO and COO rolesmsn.com - January 25 at 9:35 AMKronos Bio Implements New Leadership Structure to Drive Pipeline Advancementfinance.yahoo.com - January 25 at 9:35 AMKronos Bio, Inc.: Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidatefinanznachrichten.de - December 20 at 7:49 PMKronos Bio Stock (NASDAQ:KRON), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 19 at 11:53 PMKronos Bio Receives Buy Rating from Analyst Amid Promising Pipeline Developmentsmarkets.businessinsider.com - December 19 at 11:53 PMCancer Player Kronos Bio To Stop Lanraplenib Combo Therapy Blood Cancer Studymarkets.businessinsider.com - December 19 at 6:53 PMKronos Bio: Data From Lanraplenib Study to Treat Type of Leukemia Doesn't Support Continuing to Phase 2marketwatch.com - December 18 at 7:28 PMKronos ends development of larnarplenib combo therapy for AMLmsn.com - December 18 at 7:28 PMKronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidatefinance.yahoo.com - December 18 at 7:28 PMKronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conferencefinance.yahoo.com - December 4 at 8:49 AMStrategic Financial Management and Promising Clinical Trials Underpin Buy Rating for Kronos Biomarkets.businessinsider.com - November 28 at 8:52 AMKronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conferencefinance.yahoo.com - November 27 at 8:29 PMKronos Bio CEO buys common shares worth ~$1.47Mmsn.com - November 20 at 12:56 PMKronos Bio Up 47%, Insider Buyers Are Up 31%finance.yahoo.com - November 20 at 12:56 PMKronos Bio, Inc.: Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Resultsfinanznachrichten.de - November 14 at 12:28 PMKronos Bio GAAP EPS of -$0.54 misses by $0.03, revenue of $0.92M misses by $0.48Mmsn.com - November 14 at 2:24 AMKronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Resultsfinance.yahoo.com - November 13 at 4:23 PMKronos Bio Inc Ordinary Shares KRONmorningstar.com - November 5 at 8:07 PMKronos Bio to Cut 19% of Workforce in Bid to Extend Runwaymarketwatch.com - November 2 at 6:15 PMKronos Bio Announces Plan to Optimize Resource Allocation, Restructure and Contain Costs Following Positive Preliminary Clinical Data from its KB-0742 Phase 1/2 Studyfinance.yahoo.com - November 2 at 6:15 PMKronos Bio Presents Positive Preliminary Data from the Phase 1 Dose Escalation Portion of the Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meetingfinance.yahoo.com - November 2 at 1:14 PMKronos Bio To Present Positive Preliminary Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meetingfinance.yahoo.com - October 27 at 10:00 AMKronos Bio reports data from dose escalation portion of KB-0742 studymsn.com - October 16 at 7:31 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (KRON), Quest Diagnostics (DGX) and UnitedHealth (UNH)markets.businessinsider.com - October 16 at 9:29 AMKronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study at AACR-NCI-EORTCfinance.yahoo.com - October 13 at 1:58 PMKronos Bio To Present Interim Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at AACR-NCI-EORTC and Host Virtual Investor Event on October 13finance.yahoo.com - October 4 at 5:34 PMKronos Bio announces departure of CFO, Head of Corporate Development Al-Wakeelmsn.com - August 17 at 5:11 PMKronos Bio CFO Yasir Al-Wakeel To Step Downmarkets.businessinsider.com - August 17 at 5:11 PM Get Kronos Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRON and its competitors with MarketBeat's FREE daily newsletter. Email Address His win rate puts Warren Buffett to shame… (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss. Click here now for the full story. KRON Media Mentions By Week KRON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRON News Sentiment▼0.000.33▲Average Medical News Sentiment KRON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRON Articles This Week▼21▲KRON Articles Average Week Get Kronos Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RPHM News Today SCYX News Today GANX News Today FIXX News Today KZR News Today ELDN News Today EQ News Today HCWB News Today IMMX News Today MURA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRON) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressGreat Crypto BullWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kronos Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
